Healthcare: Drug appraisal - A matter of life and death
By Gemma O'Reilly, PR Week UK, 01 September 2009, 6:00am
'Patient power' has transformed the PR strategies around new drugs - but at what cost? And what is the other side of the story? Gemma O'Reilly investigates.
Share this story
To continue enjoying this article, please sign in. You can register for free for limited further access, or subscribe now for full access to all our content. View our subscription and registration options.









